Tag Archives: HPTN 052

Henan province study shows HIV treatment offering greater protection against transmission as drugs, programs improved

By on .

Findings suggest that quality of care required to reduce HIV transmissions can be achieved in resource-poor and remote settings Selling blood brought in more money, quicker, than farmers across Henan province in China could earn any other way, but the practice came at an even higher price. By 1997 when the government cracked down on […]

Cambodian sex workers describe barriers to HIV prevention, rights advocates track a widening treatment divide, and researchers look at syringe sharing . . . We’re reading about access to health services as a human right

By on .

The hidden world of Cambodian sex workers – Last week we were reading a study highlighting how an anti-sex trafficking law enacted in Cambodia to protect women was having the unintended and opposite effect of standing between women and vital health services. In this video, reported and produced by Steve Sapienza, you can hear about […]

What comes after START? We’re reading about a projected cost of universal access and other barriers to treatment

By on .

Treating HIV Patients Before They Get Sick – This New York Times editorial follows the newspaper’s reporting on findings from the Strategic Timing of AntiRetroviral Treatment study, which found that treating people for HIV upon diagnosis averts illnesses without adding negative impacts. The findings, the editorial says, raise the question of: “whether global and national […]

A bargain too! Analysis shows early HIV treatment provides good economic value, along with health and transmission prevention

By on .

The landmark HPTN 052 study, which proved in 2011 that treating HIV also prevents transmission of the virus, continues to be the gift that keeps on giving, with data from the multi-site trial now showing that early treatment is cost-effective as well, results of a just-released analysis reported in the New England Journal of Medicine […]

HPTN Annual Meeting: Is “PopART” research, or just good health practice?

By on .

It sounds obvious, urgent, and ambitious: Make HIV counseling and testing as well as links to subsequent care and prevention services universally available, and watch the numbers of new infections drop steeply.

Increasingly, Richard Hayes of the London School of Hygiene and Tropical Medicine said Monday, it also sounds practical.

HPTN Annual Meeting: “One thing begets another . . .” from questions, to discoveries, to policy

By on .

The HIV Prevention Trials Network is holding its annual meeting in Washington, DC this week, and Science Speaks is there, covering Monday, Tuesday and Wednesday sessions. Can community involvement in HIV testing make an impact on the stigma that has clung to the disease and hindered treatment? Can paying teenage girls to stay in school […]

Panel members: Policy stemming from PEPFAR evaluation needs to integrate “earthquake” that happened in its midst

By on .

When a report evaluating the impact of the President’s Emergency Plan For AIDS Relief produces recommendations that give little weight to the most recent major scientific breakthrough in HIV research, what will its impact on policy be? That ended up being one of the central questions in a panel discussion April 30, at the Center […]

Dr. Myron Cohen: Treatment as prevention is a bridge to the future

By on .

Dr. Myron Cohen had a broken arm in a sling, was talking on a subject he has discussed scores of times before, but all the same, he was having a good time. “It’s a really exciting time to be in AIDS research,” he explained. He was talking to an audience Wednesday evening at the George […]

ID Week: A last look at AIDS, from beginning to end

By on .

SAN DIEGO, CA — Do you remember where you were at the beginning of AIDS? Diane Havlir, who gave ID Week’s final talk on the epidemic, likes to ask that at the start of a talk, although she is increasingly aware that some of the physicians and researchers she is speaking to were children back […]